INO

INO

USD

Inovio Pharmaceuticals Inc. Common Stock

$2.430+0.000 (0.000%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.430

Kõrge

$2.575

Madal

$2.410

Maht

1.91M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

129.1M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

1.60M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $1.3Praegune $2.430Kõrge $5.8

Seotud uudised

PR Newswire

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Vaata rohkem
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
PR Newswire

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Vaata rohkem
INOVIO Reports Inducement Grant Under Inducement Plan
PR Newswire

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Vaata rohkem
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
PR Newswire

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Vaata rohkem
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
PR Newswire

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

Vaata rohkem
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.